Free Delivery Over $100
|
|
|||
|
||||
OverviewInternational Review of Cell and Molecular Biology reviews and details current advances in cell and molecular biology. This most current release in this highly cited series focuses on such timely topics as novel treatments in immunotherapy in breast cancer, chemokine receptor signaling and the hallmarks of cancer, tumor-targeting antibodies, and a section on mitochondrion and whether they are a common organelle for cell death. As always, readers will find the articles in this series to be of great value, with a high impact and average cited half-life of nine years. The IRCMB series has a worldwide readership, maintaining a high standard by publishing invited articles on important and timely topics that are authored by prominent cell and molecular biologists. This great resource ranks high amongst scientific journals dealing with cell biology. Full Product DetailsAuthor: Lorenzo Galluzzi (Assistant Professor of Cell Biology in Radiation Oncology, Department of Radiation Oncology, Weill Cornell Medical College, NY, USA)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Volume: 331 Weight: 0.450kg ISBN: 9780128124697ISBN 10: 0128124695 Pages: 396 Publication Date: 20 March 2017 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of Contents1. Immunotherapy and breast cancer: novel treatments for an old disease Luis de la Cruz-Merino Sr. 2. Cellular stress responses and metal toxicity Quan Lu 3. Roles for Src signalling in the regulation of stem cell function Jesus Espada 4. Mitochondrion: a common organelle for distinct cell deaths? Catherine Brenner 5. Chemokine receptor signaling and the hallmarks of cancer Santos Manes 6. STAT transcription factors in T-cell health and disease Mark H Kaplan 7. Tumor-targeting antibodies: novel functions for old molecules Ediwn Bremer and Djoke HendriksReviewsAuthor InformationLorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology. Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience. Tab Content 6Author Website:Countries AvailableAll regions |
||||
